+0.93±1.51 X 10-3 S-', respectively), except that 4 out of 11 nonviable tissue samples had negative kTs. At reperfusion, viable myocardial samples were all positive (+1.26±1.58 X 10-3 s-'), whereas all irreversibly injured tissues had a negative kT, indicating leakage of tracer (-1.50±1.10 X 10-3 s', P < 0.001). This study suggests that Rb-82 time-activity curves can be useful to determine patency of an infarct related artery and potential viability after reperfusion during myocardial infarction.
Introduction
Several radiotracers have been used to estimate infarct size qualitatively using single photon emitting isotopes such as thallium-20 1 and technetium-99m-pyrophosphate (1) (2) (3) (4) (5) . However, the physical properties of these tracers preclude precise quantification and their long half-lives limit them to a single study in an ischemic process that is undergoing continual evolution. Positron emitting tracers obviate the physical limitations of single photon emitters since quantification can be achieved using coincidence detection methods with positron = 25 d) generator system (10). In a recent series of studies from our group, we validated a two-compartment model for the determination of first pass extraction fraction using and beta probes positioned on the epicardial surface (1 1, 12). Epicardial flow was measured accurately over a range of up to eight times normal flow and under a variety of conditions designed to alter extraction fraction.
The hypotheses of the current study are that patency of a coronary artery can be noninvasively determined based on flow measured by Rb-82, and that irreversible injury affects myocardial cellular membrane function, which can be noninvasively detected using time-activity curves from Rb-82.
Methods
Animal preparation. 20 fasted mongrel dogs were anesthetized with sodium pentobarbital (30 mg/kg), intubated, and ventilated with room air by a volume respirator (Harvard Apparatus Co., Inc., S. Natick, MA). Arterial pressure was monitored through a transfemoral aortic catheter and lead II of an electrocardiogram was monitored using standard subcutaneous leads. A left thoracotomy was performed in the fifth intercostal space and the heart was suspended in a pericardial cradle. The left anterior descending coronary artery (LAD) was isolated just distal to the first diagonal branch, where a snare occluder was placed. A heparinized catheter was then inserted into the aorta via the right carotid artery and connected to a withdrawal pump (Harvard Apparatus Co., Inc.).
Positron radioactivity was measured using a pair of collimated beta radiation detectors (1-cm diam) positioned on the left ventricular epicardial surface between the LAD and second diagonal branches (I 1, 12). One probe was faced with 1 mm of lead to allow background gamma radiation correction. The epicardial position of the unshielded probe was marked with methylene blue at the beginning of the experiment. The detected positron counts were processed by a pulseheight analyzer (EG & G Ortec, Oak Ridge, TN) connected on-line to a Vax 11-780 computer that generated time-activity curves corrected for physical decay of Rb-82.
Experimental protocol. 2-3 mCi of Rb-82 in 10 ml of normal saline were eluted from a Sr-82 -Rb-82 generator and injected as a bolus into a femoral venous catheter immediately followed by a 10-cm3 normal saline flush. An arterial sample was withdrawn at a 1. Abbreviations used in this paper: k,, rate constant into the cellular space; k2, rate constant out of the cellular space; kT, rate constant for net transfer of rubidium-82; LAD, left anterior descending coronary artery; NAD, nicotinamide adenine dinucleotide; Rb-82, rubidium-82; TTC, triphenyl tetrazolium chloride; TTC-, TTC negative; TTC+, TTC positive. constant rate by a withdrawal pump (Harvard) to serve as an arterial reference for flow and uptake measurements.
After base-line recordings of rubidium time-activity curves, coronary occlusion was produced for one (n = 8), three (n = 4), or six (n = 8) followed by reperfusion after one of these three periods of occlusion by release of the snare occluder. Rubidium time-activity curves were obtained at base line, immediately after reperfusion, and 30 min after reperfusion in all animals.
Animals were then killed with an overdose of barbiturates and their hearts were excised. The patency of the LAD was confirmed by visual inspection and the heart was then sectioned into 1-cm axial slices. These samples were incubated with triphenyl tetrazolium chloride (TTC) to determine histochemically whether the tissue under the unshielded beta probe had been reversibly (deep red staining) or irreversibly injured (pale staining) as previously described (13) (14) (15) . Since the range of the positron particles recorded by the beta probe is only 3-4 mm, only the 4 mm of myocardium under the unshielded probe was used for comparison with Rb-82 measurements (16) . Areas were reported as TTC negative (TTC-) if there was evidence of irreversible damage within this sample.
Analysis of rubidium time-activity curves. Beta probes have a high detection efficiency for positron particle radiation and a low efficiency for gamma photon radiation (1 1). To obtain positron radioactivity per se, the time-activity curve obtained with the lead-faced beta detector (gamma radiation only) was subtracted by computer from the detector without lead (positron and gamma radiation). Regional myocardial positron radioactivity was recorded at 1-s intervals for 150 s. The same probes were then placed over a 150-ml beaker (5.5-cm diam) containing the arterial reference sample for the same interval to determine the integrated delivered dose. Since the surface area of the beaker is much greater than the probe diameter, the geometry and sample volume of blood and myocardium can be considered the same.
Myocardial flow was determined using the following equation (17): 
Results
Rubidium uptake after coronary occlusion and reperfusion.
Epicardial uptake in the LAD distribution averaged 0.72±0.15 at base line. There were no differences in control uptake between samples that were subsequently TTC positive (TTC+) (n = 9) or TTC-(n = 11) at necropsy (Fig. 1) . Uptake of rubidium decreased after coronary occlusion to 0.15±0.06 in samples that were TTC-at necropsy compared with 0.36±0.19 in TTC+ samples (P < 0.01). Reperfusion resulted in increased uptake in both groups but was less marked in TTC-samples (0.52±0.16 vs. 0.85±0.34, P < 0.01). Whereas the difference between occlusion and reperfusion rubidium uptake for each sample was significant, uptake alone did not provide a clear discriminator of patency between the occlusion TTC+ group and the reperfused TTC-group.
Rubidium flow after coronary occlusion and reperfusion (Fig. 2) . Epicardial flow by Rb-82 was 2.04±0.70 and 1.88±0.86 ml/min per gram at base line in samples that were TTC+ and TTC-, respectively, at necropsy (P = NS). Occlusion decreased flow to 0.41±0.08 ml/min per gram in TTC+ samples and to 0.32±0.08 ml/min per gram in TTC-samples (P < 0.05 TTC+ vs. TTC-, P < 0.001 vs. base line for both). At reperfusion, flow increased significantly in both regions but less in TTC-samples that paralleled the changes noted in uptake of rubidium. Flow increased to 2.73±0.56 in TTC+ samples but only to 1.58±0.78 ml/min per gram in TTC-samples (P < 0.002). Similar values were obtained by microspheres (2.89±0.55 and 1.70±0.78 ml/min per gram, respectively). These differences in flow are consistent with a component of the no-reflow phenomenon in irreversibly injured tissue samples (20) . In all animals, flows by Rb-82 exceeded 1.0 ml/min per gram after reperfusion, whereas flow was <0.5 in all samples during occlusion. Thus, in contrast to changes in rubidium uptake, rubidium flow measurements provided a good indicator of reflow.
Transfer rate constant after occlusion and reperfusion. Relation of rubidium and microsphere determined flow. The relation of epicardial flow during occlusion and reperfusion determined by Rb-82 time-activity curves and microspheres is shown in Fig. 6 . Although the correlation coefficient for this relation is high, the slope at 0.80 indicates that rubidium flow underestimates flow measured by microspheres. This result is not unexpected considering the model used in determining flow. The assumption made in the previous study is that during the first pass of tracer through the tissue, there is very little egress of tracer (11, 12 several minutes are required for each data point (21 Newer positron imaging systems have improved the temporal resolution by incorporating the time-of-flight of the photon pair, which improves the statistical accuracy of acquired counts (23, 24) . Positron tomography has superior spatial resolution because of coincidence detection of the two photons emitted during positron decay, which limits random counts and allows quantification. In this study, the positron decay was detected, not annihilation photons. This approach allows frequent sampling of counts and is a more convenient experimental model for analysis of tracer kinetics than can be achieved with a positron camera since it avoids partial volume errors or significant motion artifacts.
Flow measurements with Rb-82. Several potassium analogues such as thallium, rubidium, and ammonium have been used to assess regional myocardial perfusion (11, 12, (25) (26) (27) (28) . Uptake of these tracers is linearly related to flow up to 1.5-2.0 times resting flow, but the relationship plateaus at high flows such that uptake underestimates high flow (12, 24, 29) .
An earlier study from our group employed a two-compartment model for determination of extraction of Rb-82 during first pass of the tracer (11, 12) . This model includes two assumptions pertinent to this paper. First, the venous egress at the time of peak counts is assumed to be minimal. For this assumption to be valid, the duration of the bolus must be shorter than the capillary transit time. A computer simulation of detected arterial and venous activity was conducted under an assumption that the venous output function was identical to the arterial input function (30) . This approach resulted in a 23% underestimation of true flow. To completely validate the model experimentally, additional studies are requited to determine its limitations and potential applicability.
Previous experiments have been performed to evaluate this approach as an estimate of flow including studies during acidosis and alkalosis, inhibition of the Na-K ATPase pump, a-blockade, and administration of glucose and insulin. Despite these metabolic alterations that affected membrane extraction, the model for flow was accurate within 10% of true flow since changes in extraction were determined with the model and were accompanied by similar changes in uptake. Flow by the model with Rb-82 as the tracer was linearly related to microsphere-determined flow in the same sample volume up to eight times base line, with relatively little scatter of data.
The second assumption of the Rb-82 flow model is that Rb-82 leakage is negligible for the observation period of the time-activity curve (150 s). In this study, flow measurements with Rb-82 were linearly related to microsphere flows but with considerably more scatter and more underestimation of flow than in studies in which tracer doesn't leak from cells. These results occurred for the following reasons. The assumption that there is minimal egress of Rb-82 did not hold for TTCregions during occlusion or reperfusion. It is not surprising that membrane function and thus the rate constant for egress of tracer would be significantly affected by prolonged occlusion. Reperfusion might be expected to accelerate this process because reactive hyperemia immediately after release of the occlusion may produce capillary membrane damage (20, 31) . Thus, the measurement of myocardial uptake of Rb-82 at 150 s after bolus injection would be expected to yield artifactually low measurements of flow using Rb-82 due to leakage of tracer from the field of interest. The lower net initial uptake is probably less critical since the algorithm used for extraction estimation only includes the first 30 s of data. Nevertheless, this change in membrane permeability would be expected to affect estimated extraction. Measuring the flow earlier, i.e., within In the present study, Rb-82 uptake and flow measurements were significantly lower in TTC-regions than TTC+ regions during occlusion and reperfusion. A more specific finding associated with TTC-regions was a negative rubidium kT that was present in 4 out of 11 (36%) during occlusion and all 11 after reperfusion. None of the TTC+ samples had a negative kT (specificity = 100%). It seems that the mechanism responsible for a negative kT is the presence of membrane leakage. A negative kT has not been observed after any of the interventions performed in the earlier study from our group (12). Note that reversibly injured tissue was not significantly different from base-line values of kT, suggesting that cellular membrane function was intact until irreversible injury occurred. The observed changes in kT can be derived from the simple model shown in Fig. 7 . The model consists of two compartments: an extracellular space, and cellular space along with rate constants into (k1) and out of (k2) the cellular space. The changes in counts seen by a beta probe, P, at time t can be described by the following equation: (2) where V and C represent the volume and concentration of radioactivity in the extracellular (E) and myocardial cellular (M) spaces, respectively, at time, t.
In the method used to measure flow, k2 is assumed to be negligible under control conditions. If this assumption is valid, equation (2) can be written as follows: dP(t) = VECE(t)kl. (3) Changes in probe count activity after first pass (60-150 s) would be monoexponential and thus kT would approximate kI. This approach also seems tenable for potentially viable, ischemic, or reperfused myocardium. However, irreversible injury after reperfusion displayed a net loss of activity after first pass of the tracer indicating leakage and therefore a significant increase in k2. If k2 is much greater than kI, equation (2) 
Control TTC+
The monoexponential rate constant, kT, would thus reflect k2 under these conditions. To validate this model, intracoronary injection of tracers will need to be performed to obtain a direct measurement of k2-The results must also be interpreted with regard to the reliability of TTC staining as an indicator of irreversible damage. Tetrazolium salts accept electrons in reactions catalyzed by dehydrogenases. It was originally thought that depletion of dehydrogenases was the mechanism by which failure to take up TTC indicated irreversible damage. However, recent evidence suggests that staining is dependent on nicotinamide adenine dinucleotide (NAD) since the addition of NAD or succinate restores staining in infarcted tissue (13) . The mechanism by which NAD loss occurs is unclear.
TTC has been accepted as an indicator of irreversible damage by several investigators and confirmed by ultrastructural analysis (13) (14) (15) . This approach may underestimate the area of necrosis if NAD has not had sufficient time to be washed out of the tissue. Reperfusion as performed in this study overcomes this potential problem (13) .
The use of Rb-82 in this study offers a significant advantage over metabolic tracers because it is readily obtained from a generator and does not require additional chemical processing before administration. Background activity is insignificant after 10 min because of the short half-life such that serial injections could be performed to assess the effects of interventions.
Conclusion. Time-activity curves obtained using Rb-82 and beta probes can be used to determine patency of a coronary artery after experimental occlusion and reperfusion. Viability, based on the presence of TTC staining, can be determined by the Rb kT, which is a measure of membrane integrity after reperfusion. Further studies with a preparation that includes a pre-existing coronary stenosis are required to test these principles before these results can be related to infarction associated with chronic stenoses in man.
